Moderna
MRNA
#1190
Rank
S$24.65 B
Marketcap
S$62.41
Share price
-7.84%
Change (1 day)
52.80%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -S$4.18 Billion

According to Moderna 's latest financial reports the company's current earnings are S$2.20 Billion. In 2024 the company made an earning of -S$4.6 Billion, an increase over its 2023 earnings that were of -S$5.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$4.18 Billion-9.1%
2024 -S$4.6 Billion-8.22%
2023 -S$5.01 Billion-140.65%
2022 S$12.30 B-27.81%
2021 S$17.04 B-1911.15%
2020 -S$0.95 Billion44.7%
2019 -S$0.66 Billion28.63%
2018 -S$0.51 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.51 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.95 B-619.94%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$29.59 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-S$60.79 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.53 Million-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.16 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$0.18 B-104.48%๐Ÿ‡บ๐Ÿ‡ธ USA